Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
OtherCorrespondence

Author’s Reply

Robert S. Bobrow
The Journal of the American Board of Family Practice July 2005, 18 (4) 328a-328; DOI: https://doi.org/10.3122/jabfm.18.4.328a
Robert S. Bobrow
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

To the Editor: In her critique of our article, Dr Hoffman states that factor V Leiden and the prothrombin gene mutation were not evaluated in the three patients. They were. The “NP” in the table means “not present” (see key under table).

That factor VIII can be an acute phase reactant seems to be common knowledge. However, I listed 3 references1–3 that specifically examined this in patients with venous thromboembolism (VTE) and concluded that the increase in factor VIII was “persistent and independent of the acute phase response.” O’Donnell et al1 use that specific phrase in their title and find 94% of 35 VTE patients with elevated FVIII to have a persistent increase, independent of CRP and fibrinogen. O’Donnell et al2 found elevated FVIII to be the single most common risk factor in 260 VTE patients and also stated that it did not correlate with CRP or fibrinogen. Kamphuisen et al3 reached the same conclusion. (“Increased levels of FVIII and fibrinogen in patients with VTE are not caused by acute phase reactions.”)

I would have liked to have had CRP and fibrinogen levels on my patients, but this was a retrospective study and none were done.

References

  1. ↵
    O’Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase reaction. Thromb Haemost 2000; 83: 10–3.
    OpenUrlPubMed
  2. ↵
    O’Donnell J, Tuddenham EG, Manning R, Kemball-Cook G, Johnson D, Laffan M. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 1997; 77: 825–8.
    OpenUrlPubMed
  3. ↵
    Kamphuisen PW, Eikenboom JC, Vos HL, et al. Increased levels of factor VIII and fibrinogen in patients with venous thromboembolism are not caused by acute phase reactions. Thromb Haemost 1999; 81: 680–3.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Practice: 18 (4)
The Journal of the American Board of Family Practice
Vol. 18, Issue 4
July-August 2005
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Author’s Reply
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Author’s Reply
Robert S. Bobrow
The Journal of the American Board of Family Practice Jul 2005, 18 (4) 328a-328; DOI: 10.3122/jabfm.18.4.328a

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Author’s Reply
Robert S. Bobrow
The Journal of the American Board of Family Practice Jul 2005, 18 (4) 328a-328; DOI: 10.3122/jabfm.18.4.328a
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Hepatitis C Treatment Knowledge, Attitudes, and Practices Among Primary Care Providers—Los Angeles County, 2023
  • Re: Factors Influencing Patient Confidence in Screening Mammography
  • Re: Physician and Advanced Practice Clinician Burnout in Rural and Urban Settings
Show more Correspondence

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire